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Abstract
Freezing of gait (FOG) in Parkinson’s disease (PD) rises in prevalence when the effect of medications decays. It is known
that auditory rhythmic stimulation improves gait in patients without FOG (PD-FOG), but its putative effect on patients
with FOG (PD+FOG) at the end of dose has not been evaluated yet. This work evaluates the effect of auditory rhythmic
stimulation on PD+FOG at the end of dose. 10 PD+FOG and 9 PD-FOG patients both at the end of dose periods, and 10
healthy controls were asked to perform several walking tasks. Tasks were performed in the presence and absence of
auditory sensory stimulation. All PD+FOG suffered FOG during the task. The presence of auditory rhythmic stimulation
(10% above preferred walking cadence) led PD+FOG to significantly reduce FOG. Velocity and cadence were increased,
and turn time reduced in all groups. We conclude that auditory stimulation at the frequency proposed may be useful to
avoid freezing episodes in PD+FOG.
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Introduction
The gait of people with Parkinson’s disease (PD) is characterised
by a number of well-defined features. From a kinematic point of
view PD exhibit a reduction in step length and velocity [1-3],
decreased angular displacement and velocity of lower and upper
limbs [4], high stride cycle time variability [5,6], poor bilateral
coordination [7] or asymmetric leg function [8]; and difficult in
turning (displaying a block-like pattern [9]). There are other less
frequent gait disturbances in PD, among which freezing of gait
(FOG) is one of the most disabling. Of unknown origin, FOG is
characterised by a sudden loss of the ability to start or continue
walking, as if the patient’s feet were glued to the ground, which
can lead to falls and injuries [10].
FOG is typical in advanced phases of the disease and it seems
associated with disease duration, its grade of development, longer
duration of levodopa treatment, levodopa-induced dyskinesias
[11,12], as well as early morning dystonia and postural instability
[12].
Three main forms of FOG have been identified [13]: a purely
akinetic form; a ‘‘tremble in place’’ type at which the patients’ legs
can tremble between 2–4 Hz [14], and a ‘‘shuffling’’ form with
small steps.
Based on the poor correlation between FOG and UPDRS sub-
scores [15] has been suggested that FOG has a different origin
when compared to other clinical features, such as rigidity or
bradykinesia. Also, the EMG profile prior to freezing has shown
an altered premature discharge pattern in antagonist leg muscles
[16]. This feature may be related to the reported increase in the
CVstride-time in advanced PD [6,17], the poor bilateral coordina-
tion [7] and asymmetric motor function in patients suffering FOG
[8]. All these characteristics support that loss of control of the
regulation of cadence brings about FOG [18].
FOG is chiefly triggered at onset of walking and during turning,
but also at narrow spaces (such as doorways) (see supporting
information multimedia files Videos S1 and S3) or when
approaching targets [11,19]; its duration is usually less than
10 sec, and rarely longer than 30 sec [13,19]. Administration of L-
dopa can reduce FOG [19], which is more common when
medication wears off, suggesting dopamine deficiency as a cause
[10], although pedunculopontine nucleus degeneration may also
have a role [20,21].
Although the effect of auditory rhythmic cueing on gait in PD is
well documented [6,22–27], reports assessing its role on FOG are
much scarcer. Lack of effect on FOG (or even worsening) was
reported using auditory [28,29], as well as other cueing strategies
(visual-spatial stimulation [30]). In addition Enzensberger and
Fischer [31] have found a significant reduction in the number of
freezing episodes at turning and on straight walking in Parkinsonian
patients ON-dose while using auditory stimulation at a fixed
metronome frequency for all patients. Our objective is to determine
the impact of auditory stimulation on FOG when the effect of the
medication has decayed, but importantly using a frequency of
stimulation normalised as a function of gait pattern of each patient.
Methods
Objectives
The aim of our study was to investigate the effect of rhythmic
auditory stimulation on the gait of Parkinsonian patients who
exhibit significant FOG (PD+FOG) during their end of dose-periods.
Based on previous results [6,32], the frequency of stimulation was
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preferred walking. Stimulation at this frequency is known to
reduce the CV of stride time [6,32] which is associated with FOG
[17]. The research hypothesis is that auditory stimulation at the
frequency proposed modifies the walking pattern in PD+FOG,
reducing the freezing episodes.
Participants
Participants in the study were recruited from a total of 80
patients belonging to the Asociacio ´n Parkinson Galicia and the
Asociacio ´n Parkinson Ferrol (Spain). All patients were only orally
medicated, without surgical operation for PD.
PD+FOG. Patients in this group, who exhibited significant
FOG (PD+FOG), had to match the following criteria:
N diagnosis of idiopathic PD based on the UK Parkinson’s
Disease Society Brain Bank for clinical diagnostic criteria
N history of freezing during walking from medical records, and
score .10 (all PD displaying $2 in item #3) in the Freezing of
Gait Questionnaire (FOGQ) [33]
N predictable motor fluctuation related to dose intake, deter-
mined from medical records and examination by a neurologist
N lack of auditory-visual impairment, musculoskeletal injury, and
MMSE score .24
N at the moment of testing, during the end of dose period, they
should be able to walk 6m unaided, turn around and come
back despite the freezing episodes, which should be present
during preferred walking condition (un-cued, at the end of
dose)
N during ON periods they should be able to walk without
freezing
10 volunteer PD+FOG matched the criteria and underwent the
experimental protocol (6 males, 4 females; 68.20 yrs (68.03),
trochanteral height 0.89 m (60.06), FOGQ score 16.70 (64.81).
Patients did not expect any benefit in their gait patterns from the
cues, as their use was explained to be a method to characterize
gait. No patient had previous experience on gait cueing.
PD-FOG. 9 volunteer PD, without history of FOG (PD-
FOG), were also recruited (6 males, 3 females; 64.44 yrs (69.50),
trochanteral height 0.88 m (60.04). Inclusion criteria were the
same as stated for PD+FOG, with the exception of those criteria
related to FOG. The score in the FOGQ had to be zero to be a
possible subject in this group.
CONTROL SUBJECTS. 10 healthy subjects (people from
our institution and relatives) were selected as the Control group
(8 males, 2 females; 70.20 yrs (66.84), trochanteral height 0.89 m
(60.04); they were also screened for gait or balance impairment.
Description of Procedures
Subjects were asked to walk along a corridor (with a door in the
middle), touch a button on the wall at the end, turn around, come
back and touch the button on the other wall, this task in
conception and distance included FOG evoking elements.
Patients came to our laboratory on two consecutive days. The
first day they undertook MMSE, UPDRSon and the first two trials
(Baseline) at their preferred walking pattern without the door in
the middle of the corridor in order to determine baseline cadence,
for which the turn was excluded; all this was carried out during
patients’ ON-periods (after patients confirmed to be in ON [34], and
under observation by a neurologist).
During the next day, at the end of dose, patients performed the
UPDRS-III and 4 trials (2 at their preferred walking without
auditory stimulation (PW) and 2 with the stimulation at a
frequency 10% faster than the cadence at baseline (110A), both
with the door in the middle of the corridor); healthy controls
performed the 6 trials in the same day. End of dose was defined as
‘‘deterioration and recurrence of parkinsonian symptoms as a result of shorter
(sometimes only 1 to 2 hours) duration of benefit after a given dose of L-dopa.’’
[35]. Trials were performed in this sequence to avoid stimulation
carryover effect (i.e. the effect that cueing in one trial might have
on a subsequent un-cued trial) which has been reported in the
literature [22]. In this paradigm we used a frequency of
stimulation determined during the ON period, to be used at the
end of dose time epoch. This method is supported by previous
work showing an effect of medication on stride time variability but
not in cadence either in PD+FOG and PD-FOG [17]. This work
also showed that cadence is not different between PD+FOG and
PD-FOG [17], regardless of the medication state.
The instruction given to the subjects was ‘‘walk along the corridor as
you normally do, touch the button on that wall and without stopping turn
around, come back, and touch this other button on this wall’’ (figure 1). For
the stimulation conditions the instruction given was ‘‘do the same
as before, but matching your steps to the rhythm’’. No specific
instruction was given in order to manage turns.
All patients were evaluated in the morning after a light breakfast
to avoid interference of possible protein intake at lunch, which
could lead to L-dopa absorption problems. At the moment of
testing PW and 110A patients confirmed to have lost the effect of
medication [34]; wearing-off was confirmed by the neurologist.
APPARATUS. The recording system consisted of a series of
footswitches worn as insoles in the shoes. The footswitches were
connected to a radio-transmitter attached to the subjects’ belt.
Data (sampled at 1KHz) were sent to a receiver unit connected to
the computer. This configuration allowed the stride cycle time to
be registered.
Two photocells, placed 5.98 m apart, were connected to the
recording system so that the records from the moment subjects
crossed them were acquired. A portable in-house device provided
auditory stimulation (a click) by means of headphones, which
subjects wore regardless of whether or not they were stimulated.
The sound was a tone with wave-frequency of 4,625 Hz, and the
intensity was adjusted to be clearly perceived by the subjects
without being annoying. The stimuli were delivered in pulses of
50 ms and the inter-pulse duration was customized to obtain the
desired stimulation frequency.
ANALYSED VARIABLES. The number of freezing
episodes and their duration were measured by analysis of
video footage by a specialist with 10 years experience working in
a rehabilitation centre for PD, who was unaware of the protocol.
Video samples were analysed by means of video software which
allows frame identification (and/or sequencing) by simply
keyboard strokes, allowing the identification of freezing start
and end, duration and number of FOG episodes. Videos to the
specialist were presented in random order and were encoded to
avoid any kind of identification during evaluation; sound was
off. Freezing episodes were defined following the work by
Kompoliti et al. [30]: ‘‘One freezing episode was defined as stop and/or
hesitation until the next step was accomplished independently of the number
of hesitations in place’’.
In other to characterize FOG, the freezing episodes were
grouped by duration (less than 3s; 3–10s; .10s) [19,33]; and by
the circumstances under which they occurred: at turning; at the
door; at approaching the button to be touched; at walking start.
However when evaluating the effect of stimulation, those
categories were no used, and only the duration and number of
freezing episodes were considered.
Auditory Stimulation on Gait
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Velocity: Calculated as a function of the time to cover the
straight section between the photocells, expressed as m/sec.
Cadence: Obtained from footswitch data corresponding to the
straight section of the test, expressed as steps/sec.
Step length: Expressed in m as a function of the velocity and the
cadence, again measured only over the straight section.
Turn around time: Time taken from the photocell at the end of
thecorridor(figure 1),which wasactivatedbeforeandafterthe turn.
The value for each kinematic variable was the mean obtained
from the two trials performed in each condition.
Ethics
All subjects were informed about the nature of the test and
signed consent forms. The protocol was in compliance with the
Helsinki declaration and was approved by the University of A
Corun ˜a Ethics Committee.
Statistical methods
A student ‘‘t’’ test for independent samples was used to compare
the grade of disability between the groups of patients (UPDRS-III).
One-way ANOVA was used to assess differences in motor
behaviour at baseline (PW) between groups of patients and
controls, also for demographics. Alternatively, a non-parametric
Kruskal-Wallis test, and subsequent Mann-Whitney were per-
formed for those variables not matching normality.
In order to determine the effect of stimulation on the
kinematics, a 2x3 ANOVA model with repeated measures was
performed. Two factors were defined: (i) within-subjects, (factor
cue with 2 levels, PW and auditory stimulation (110A)); and (ii)
between-subjects, (factor group, with 3 level PD+FOG, PD-FOG,
and Controls). Given the parametric nature of this analysis a
Logarithmic Transformation was performed when normality was
not assumed (in the case of Turning Time for PD+FOG), so that
the variables could be introduced into the analysis. Normality of
distribution was assessed by means of one sample KS test.
A one-way Chi-Square (x
2) was performed in order to assess
differences in proportions of type of freezing episodes. Given the
task involved passing through a doorway, approaching a point,
and start walking twice each trial, and just one turn, the number of
three first types was adjusted by dividing each by two. Number
and mean duration of the freezing episodes in the PD+FOG in
presence vs. absence of stimulation were assessed by means on
non-parametric Wilcoxon test. Significance was set at p#0.05.
Results
Characterization
Differences in the UPDRS motor scores between PD+FOG and
PD-FOG were not significant (t(17)=1.163 p=0.261); proving
groups of patients were comparable in the overall disease
development, (though clearly they differed in respect of the
presence of FOG); demographics were not different along groups
p.0.05 (age: F(2,26)=1.305 p=0.288; trochanteral height:
F(2,26)=0.029 p=0.972).
Figure 1. Representation of the task carried-out by the subjects.
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characteristic differences between groups (Table 1). One-way
ANOVA showed a main effect of the group for velocity and step
length. Subsequently pos-hoc analysis showed PD+FOG walked
slower, with shorter steps, than PD-FOG and than Controls; this
was also seen in PD-FOG vs. Control. The same pattern was
displayed for the time to turn as proved by Kruskall Wallis and
subsequent Mann-Whitney tests. One-way ANOVA showed,
however, that cadence was not difference across groups.
All the PD+FOG experienced freezing during the task. A total of
59 freezing episodes (see Table 2 and Fig. 2) were registered during
gait without stimulation. Most of them occurred when turning and
start hesitation, but also at the door and approaching a target (20,
21, 16, and 2 respectively; x
2(3)=18.75 p,0.001). Only 6 freezing
episodes lasted more than 10 sec; 16 lasted between 3–10 sec; and
37 lasted less than 3 sec (x
2(2)=25.46 p#0.001).
Effect of the stimulation on gait patterns
The main outcome of this study is that the number of freezing
episodes were significantly reduced in patients in presence of
auditory stimulation, from 59 to 14 (6 when turning and 8 at start
walking; Z=2.446 p=0.014). Mean duration was also signifi-
cantly reduced (Z=2.395 p=0.017); see Table 2, Fig. 2, and
supporting multimedia files, Videos S1, S2, S3 and S4. Individual
changes in the number and duration of freezing episodes are
shown in Fig. 3.
It is possible that the significant reduction in the number and
duration of FOG is due to change in very few subjects, rather than
to the whole population. For example, PD+FOG subjects number
3 and number 10 (Fig. 3) display considerable more FOG
episodes, with longer duration. To assess this, the effect of the
stimulation was also checked leaving out PD+FOG #3 and
PD+FOG #10. When analysed this way the effect of stimulation
Table 1. Characterization of gait kinematics for PD groups and Control in absence of stimulation.
PD+FOG PD-FOG Control F-p values//KW
PD+FOG vs.PD-FOG PD+FOG vs. Control PD-FOG vs. Control
Velocity (m/s) 0.580 (60.313) 0.967 (60.214) 1.237 (60.160) F(2,26)=19.115 p,0.001
p=0.002 p,0.001 p=0.021
Step length (m) 0.337 (60.174) 0.531 (60.079) 0.674 (60.061) F(2,26)=20.711 p,0.001
p=0.001 p,0.001 p=0.001
Cadence (steps/s) 1.727 (60.338) 1.819 (60.185) 1.831 (60.125) F(2,26)=0.573 p=0.571
Turning Time (s) 26.886 (658.690) 3.850 (61.083) 2.493 (60.557) x
2 (2)=18.796 p,0.001
7.515 [3.45–193.30] 3.934 [1.81–5.00] 2.397 [1.63–3.49] p=0.004 p,0.001 p=0.009
Values: Mean, (6sd), median, [range]. Units: (m/s)=meters/second; (m)=meter; (steps/s)=steps/second; (s)=seconds; (n.s)=not significant. Median and range are
shown for variables not matching normality. F value for One-Way ANOVA is reported, along with comparisons between groups when significant effect is displayed. For
Turning Time, given its non-parametric nature KW test was performed, and subsequent Mann-Whitney test to compare difference between groups. Velocity, step length
and turning time were impaired in PD with regards to Controls, and also PD+FOG presented greater degree of impairment than PD-FOG.
doi:10.1371/journal.pone.0009675.t001
Table 2. Effect of the stimulation on walking parameters.
PW 110A
ANOVA: Factor Cue (C); Factor group (G); and their
interaction (C*G)
Velocity (m/s) 0.927 (60.361) 1.008 (60.328) C: F(1,26)=8.437 p=0.007 C*G: F(2,26)=1.845 p=0.178 G:
F(2,26)=19.050 p,0.001
Step length (m) 0.513 (60.182) 0.532 (60.154) C: F(1,26)=1.842 p=0.186 C*G: F(2,26)=2.451 p=0.106 G:
F(2,26)=21,592 p,0.001
Cadence (steps/s) 1.792 (60.232) 1.878 (60.184) C: F(1,26)=5.857 p=0.023 C*G: F(2,26)=0.283 p=0.756 G:
F(2,26)=0.619 p=0.546
Turning Time (s) 11.325 (635.212) 4.048 (62.500) C: F(1,26)=4.882 p=0.036 C*G: F(2,26)=2.255 p=0.125) G:
F(2,26)=13.537 p,0.001
PW 110A Wilcoxon
Number of freezing
episodes in PD+FOG
5.900 (66.707)
2.500 [1–22.00]
1.400 (61.265)
1.000 [0–3.00]
Z=2.446; p=0.014
Mean duration of freezing
episodes (s) in PD+FOG
3.119 (64.930)
0.910 [0.28–16.01]
1.020 (61.699)
0.665 [0–5.71]
Z=2.395 p=0.017
PW (absence of stimulation); 110A (presence of stimulation). Values: Mean, (6sd), median, [range]. Units: (m/s)=meters/second; (m)=meter; (steps/s)=steps/second;
(s)=seconds. Results for velocity, step length, cadence and turning time are shown pooled across groups because ANOVA showed lack of significant interaction
cue*group, meaning all groups were affected in the same way. Log transformations were applied to Turning Time in order to make distributions adjusted to normality
so that making parametric analysis applicable, its mean and (6sd) are plotted without transformation to make interpretation feasible. The stimulation led to increased
velocity and cadence, and also to reduce the time to turn, which was seen in the three groups.
Variables related to freezing are only related to PD+FOG, median and range are shown as variables were not matching normality. Stimulation led both to reduce the
number and the mean duration of the freezing episodes.
doi:10.1371/journal.pone.0009675.t002
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p=0.040) and mean duration of motor blocks (Z=1.960
p=0.050).
For the rest of variables, stimulation proved to affect the same
way all groups, as demonstrated by the lack of significant
interactions cue*group. Taking this into account the stimulation
led to reduce the time to turn, to increase cadence, and to increase
velocity, as proved by a main effect of factor cue for each of those
kinematics (see table 2). The increase in step length did not reach
significance, however. Significance of factor group for velocity,
step length, and turn time proved groups kept on being different
along conditions, this was expectable given they were different at
PW and they were also equally affected by the stimulation (all
main effects and interactions are reported in table 2).
Discussion
In absence of auditory stimulation the gait of the Parkinsonian
patients who ‘‘freeze’’ compared to those without freezing, and the
latter compared to controls, exhibited lower velocity, and shorter
step length, and such differences from Controls are in agreement
with previous work [26]. All PD+FOG also suffered freezing
episodes and they took longer to complete turns (vs. PD-FOG; and
Controls), PD-FOG also took longer than Controls [36].
However, the main outcome of our study is that auditory
stimulation at the frequency proposed significantly reduces the
number and the mean duration of the freezing episodes in a FOG
eliciting task, aimed to reproduce daily activities [11], and
evaluated when the effect of medication decayed (a critical time
for patients). Clearly, the effect of the stimulation in reducing FOG
is not only driven for some small sample of PD+FOG, but instead
included an overall group improvement, since the results are
consistent when all patient were analysed and when we excluded
those with the highest improvement in presence of stimulation.
Importantly, calculating the stimulation frequency during the ON
period (FOG free condition) to be used when in the OFF period is
an approach not used before. This has turned out to be useful and
would be feasible for daily use.
The reduction in FOG is in contrast to a previous study which
reported a lack of effect of auditory stimulation on FOG [28]. It
seems likely that stimulation frequency plays an important role
here, as Cubo et al. [28] utilised a frequency equalling PW
cadence, while we used 110% of preferred walking. The CV of
stride time is strongly associated with FOG [17], therefore
we decided to use a frequency which has proved to reduced
CVstride-time [6,32]; avoiding those which increase it [6,23,26]; also
Hausdorff et al. [32] have recently reported no effect on stride
time variability when the frequency of the auditory stimulation
matches PW cadence, the same frequency used by Cubo et al.
[28]. The role of the stimulation frequency seems also reinforced
by Moreau et al. [29] who proved higher auditory frequencies (20
and 40% above PW cadence) increased FOG in PD. This is
important since Moreau’s frequencies are much higher than those
reported to reduced CV of stride cycle time [6,32]. Also, our
Figure 2. Number and duration of the motor blocks experienced by the patients during walking in absence and presence of
stimulation. (m) At start walking; (¤) at turning; (- ---) at the door; (N) at approaching the target. Grey icons represent the values obtained for PD+FOG
#3 and #10. The number and mean duration of the freezing episodes were significantly reduced by the presence of the stimulation when all PD
were analysed (p=0.014, and p=0.017; respectively). When PD+FOG #3&#10 were excluded from the analysis, in order to know if change was due
to behaviour of these two extreme PD+FOG, the effect of stimulation kept on being significant, by reducing the number (p=0.040) and mean
duration (p=0.050) of motor blocks.
doi:10.1371/journal.pone.0009675.g002
Figure 3. Effect of the stimulation on gait. Mean duration (a), and number (b) of the freezing episodes for each patient. PW (absence of
stimulation); 110A (presence of stimulation).
doi:10.1371/journal.pone.0009675.g003
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normalised the frequency for each subject to +10% PW-cadence
and they selected a fixed frequency which turned out to be slightly
higher (group mean) than PW-cadence. Additionally, contrary to
other published studies [26,28,31,36], our work was carried out on
patients at the end of dose periods (when FOG prevalence is
higher [19]), rather than during the ON periods, which might also
help to explain the contrary results, as ON-freezing is resistant to
other therapeutic approaches [30,37]. It is worth saying that other
stimulation frequency has been proposed for freezers during ON-
periods [26].
The presence of the auditory stimulation interacted with the
kinematic variables the same way across our different groups of
subjects [6]. In our study auditory stimulation produced an increase
in velocity in all groups [26,31]. Interestingly, in agreement with
others [24], this increase in velocity is chiefly a result of augmentation
of cadence but not in step length, which probably reflects an
adaptation in the stride pattern made to, for instance, prepare turns,
so that explaining why the enlargement in step length is not
significant, in contrast to reports with larger walkways and without
turns [6,27,31]. Also, reduction in turning time fits well with the
reduction in the freezing episodes, with a great prevalence during
turning, and reinforces the suitability of this form of stimulation in
order to improve quality of life in the PD.
Limitations
Despite our results some questions about the effectiveness of
cueing on FOG are still open. Here, the impact of stimulation was
assessed for limited period of time, so it is pertinent to ask about its
effectiveness during repeated, daily use, give the possibility of
habituation to stimulation. Some work has reported rhythmic
auditory stimulation entrainment in PD after a programme of
auditory stimulation, modifying EMG patterns during gait [38],
kinematics [27,39], and brain activity at rest [39] in patients
without freezing, but it has not been consistently explored in
PD+FOG. Further, we have used a frequency which has been
reported to reduce stride time variability [6,32], but it could be
that other frequencies might also have an impact in FOG, this
should be explored, as well as the effect of cueing on PD+FOG
during dual-task, which has been reported to reduce attentional
cost in the case of PD-FOG when stimulation was mainly auditory
[40,41]. Also, an effect of learning exhibited during cued trials
(always performed after un-cued ones) is one option to explain
improvement, however in our opinion this can hardly account for
the effects we report, given that gait is already a well-learned
movement; appropriate randomization of a large enough set of
trials could control for the sequence effects, but carry-over effects
may also appear [22]. In addition, the protocol might also become
too heavy for the patients. In this work we have not assessed the
impact of the stimulation on CV of stride cycle time, which has
been related to FOG [17]. We deem larger straight trajectories
would be needed for this, conversely to the shorter trajectory used
in our study (with turns, door…), which was aimed to reproduce
FOG eliciting elements.
Conclusion
We conclude that auditory stimulation may be used in order to
minimize FOG at the end of dose in affected Parkinsonian
patients. Results from our study support the use of a frequency
slightly above the preferred walking frequency (as measured
during ON-periods in absence of FOG), which can then be used at
the end of dose phase. This point strongly supports other work on
the suitability of using auditory cues to improve quality of life in
PD either in controlled or uncontrolled environments [42,43].
Supporting Information
Video S1 Example of a patient (Example1) with motor blocks
(mainly at turning) during preferred walking (no stimulation).
Found at: doi:10.1371/journal.pone.0009675.s001 (7.39 MB
MPG)
Video S2 Example of the same patient shown in S1 (Example1)
with motor blocks during auditory stimulation. Walking and
turning were clearly improved.
Found at: doi:10.1371/journal.pone.0009675.s002 (2.56 MB
MPG)
Video S3 Example of another patient (Example2) with motor
blocks (mainly at crossing the door) during preferred walking (no
stimulation).
Found at: doi:10.1371/journal.pone.0009675.s003 (9.21 MB
MPG)
Video S4 Example of the same patient showed in V3 (Example2)
with motor blocks (mainly at crossing the door) during auditory
stimulation. Walking through the door was clearly improved.
Found at: doi:10.1371/journal.pone.0009675.s004 (5.70 MB
MPG)
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